Related Experiment Video

Updated: May 10, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

[Recent clinical trials of tumor immunotherapy]

Takashi Inozume1

  • 1University of Yamanashi, Department of Dermatology.

Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology
|July 2, 2013
PubMed

Insights

Immunotherapy clinical trials show significant progress in treating advanced cancers. Treatments like CTLA-4 blockade and PD-1/PD-L1 inhibition improve survival and induce tumor regression in various cancers.

Area of Science:

  • Oncology
  • Immunology
  • Clinical Research

Context:

  • Recent advancements in cancer immunotherapy have yielded promising clinical outcomes.
  • Immunotherapy strategies are being explored for various advanced solid tumors.

Purpose:

  • To review and summarize the remarkable results from recent clinical trials in cancer immunotherapy.
  • To highlight the efficacy of different immunotherapy approaches in treating advanced cancers.

Summary:

  • Blockade of cytotoxic T-lymphocyte antigen 4 (CTLA-4) has significantly improved overall survival in melanoma patients.
  • Programmed cell death 1 (PD-1) or programmed cell death 1 ligand 1 (PD-L1) blockade has led to durable tumor regression and disease stabilization in advanced melanoma, non-small-cell lung cancer, and renal cell cancer.
  • Adoptive cell transfer (ACT) using tumor-infiltrating lymphocytes (TILs) and T cell receptor (TCR) engineered T cells has shown efficacy in melanoma.
  • Cancer vaccines targeting various tumors are under investigation to prolong overall survival.

Impact:

  • These findings underscore the growing potential of immunotherapy in oncology.
  • The summarized results provide insights into effective treatment strategies for advanced cancers.
  • This review highlights the transformative impact of immunotherapy on patient outcomes.

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...